Inactive hydroxysteroid dehydrogenase-like protein 1
CAT No: ta-210
Synonyms/Alias:Inactive hydroxysteroid dehydrogenase-like protein 1 (20-27)
Inactive hydroxysteroid dehydrogenase-like protein 1 (20-27) is a synthetic peptide fragment corresponding to amino acids 20 through 27 of the human HSDL1 protein sequence. As a peptide derivative of a member of the short-chain dehydrogenase/reductase (SDR) superfamily, it provides a valuable molecular tool for investigating the structural, functional, and regulatory aspects of HSDL1 and related proteins. The sequence specificity and defined length of this peptide make it particularly suitable for a range of biochemical and molecular biology applications, including studies of protein-protein interactions, antibody generation, and functional mapping. Its inert nature, due to the "inactive" designation, allows researchers to focus on structural or binding properties without confounding enzymatic activity.
Epitope mapping: The peptide fragment representing residues 20-27 of HSDL1 serves as a precise epitope for mapping antibody binding sites. Researchers can utilize this sequence to identify or confirm the specificity of antibodies raised against HSDL1, facilitating the development of highly selective immunoassays or immunodetection reagents. By incorporating this defined segment into in vitro assays, it becomes possible to dissect the antigenic determinants responsible for immune recognition, supporting both basic immunology research and the optimization of antibody-based analytical tools.
Protein-protein interaction studies: As a representative segment of the HSDL1 protein, the 20-27 peptide enables targeted investigation of potential interaction motifs within the SDR family. By employing this peptide in binding assays, surface plasmon resonance experiments, or pull-down studies, scientists can probe the capacity of this region to mediate specific molecular contacts. Such analyses contribute to elucidating the interaction landscape of HSDL1, offering insights into its possible scaffolding or regulatory roles within complex cellular networks.
Peptide-based assay development: The well-defined sequence and manageable length of the 20-27 fragment make it an ideal substrate or standard in the design of peptide-based assays. It can be used as a calibration reference or as a competitor in competitive binding formats, thereby enhancing the quantitative accuracy and reproducibility of experimental protocols. These applications are particularly relevant in high-throughput screening environments or when validating new assay platforms targeting SDR-related pathways.
Structural and conformational studies: Synthetic peptides derived from specific protein regions, such as the 20-27 segment of HSDL1, are frequently employed in biophysical analyses to characterize secondary structure preferences, folding propensities, and conformational dynamics. Techniques such as circular dichroism spectroscopy, NMR, or molecular modeling can be applied to this peptide to gain insight into the structural features inherent to this portion of the parent protein. Such information is valuable for understanding the determinants of protein stability, folding, and potential aggregation behavior.
Functional motif analysis: The 20-27 peptide offers a platform for dissecting the contribution of discrete linear motifs to the overall function of HSDL1 and related SDR proteins. By introducing this fragment into mutational studies or functional reconstitution experiments, researchers can systematically evaluate its influence on protein localization, recognition by cellular machinery, or participation in regulatory processes. These approaches support a deeper understanding of the modular organization of protein function and the evolutionary conservation of critical sequence elements within the SDR family.
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.